Immediate revascularization of nonculprit lesions in patients with STEMI was not superior compared with deferred percutaneous coronary intervention of nonculprit lesions out to 3 years, researchers ...
These findings are published in November 2025 in The American Journal of Cardiology.
TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025Treatment ...
Morning Overview on MSN
Single intramuscular shot shows promise for faster heart attack recovery
A single intramuscular injection of a self-amplifying RNA therapy produced weeks of heart-protective protein in rat models of myocardial infarction, according to a study published in Science on March ...
Treatment with TONMYA provided statistically significant pain reduction in two Phase 3 trials and was generally well tolerated BERKELEY HEIGHTS, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Tonix ...
Lipid-lowering therapy can be considered with a 10-year PREVENT-ASCVD risk estimate of 3% to <5% (borderline) and should be considered for those at 5% to <10% (intermediate) 10-year risk. For ...
Patients who saw a cardiologist were 35 per cent less likely to die within a year of surgery and 46 per cent less likely to ...
Bio: Seemantini Nadkarni is an Associate Professor at the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School with over 20 years of experience in innovating ...
When e-cigarettes first appeared around 2010, they were hailed as a breakthrough: nicotine delivery without the toxic tar and combustion byproducts of traditional cigarettes. Public health bodies ...
The ACC and AHA released updated guidelines for the management of dyslipidemia to reduce risk for atherosclerotic cardiovascular disease.
Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:30 AM EDTCompany ParticipantsAmy Parison - Senior VP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results